AstraZeneca’s mantle cell cancer drug gets body’s nod for EU approval
HQ Team April 1, 2025: AstraZeneca’s drug to treat adult patients with previously untreated mantle cell lymphoma has been recommended for European Union.
Drugs
Health
Pharma
Health
Research
Key protein ArfGAP2 identified as driver of autoimmune diseases
HQ Team March 20, 2025: Researchers have identified a protein, ArfGAP2, that triggers harmful immune responses in autoimmune diseases, offering a novel target.
Health
Research
Aspirin shows promise in preventing cancer metastasis
HQ Team March 10, 2025: University of Cambridge scientists have uncovered the mechanism behind how aspirin could reduce the spread of certain cancers.
Health
Medical
Guillain Barre Syndrome outbreak in Pune causes one death, 73 affected
HQ Team January 26, 2025: Over 73 people are down with Guillain Barre Syndrome (GBS), a rare nerve disorder, in Pune city in.
Drugs
Health
Pharma
GSK to invest $800 million in US to double capacity at Marietta facility
GSK Plc., will invest $800 million in its manufacturing facility in the US — the largest investment to date in the country — to.
Drugs
Health
Pharma
UK scientists receive funding to develop world’s first ovarian cancer vaccine
HQ Team October 4, 2024: Researchers at the University of Oxford have received £600,000 (€719,960) from Cancer Research UK to fund their project.
Drugs
Health
Pharma
Body undergoes tectonic molecular shifts at age 44, 60: Stanford Medicine
Molecules and microorganisms in the human body dramatically rise or fall at an average age of 44 and 60 affecting both the heart.
Drugs
Health
Pharma
German male injects Covid-19 vaccines 217 times, immunity didn’t weaken
HQ Team March 7, 2024: An 82-year-old German male, who took Covid-19 vaccine 217 times, did not have his immune system weakened but.
Drugs
Health
Pharma
Hepatitis C virus uses a molecular mask to escape immune systems: Dutch research
HQ Team July 6, 2023: The Hepatitis C virus wears a “mask” and remains hidden to evade the human immune system to cause.
Drugs
Health
Pharma
AstraZeneca signs $2 billion deal for autoimmune diseases
HQ Team June 9, 2023: AstraZeneca, a British-Swedish pharmaceutical company, has signed a deal, worth more than $2 billion, with Quell Therapeutics to.